Programmed Cell Death Protein-1 Inhibitors Versus Programmed Death-Ligand 1 Inhibitors in Addition to Chemotherapy for the First-Line Treatment of Advanced NSCLC: A Systematic Review and Meta-Analysis

INTRODUCTION: The addition of programmed cell death protein-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitors to first-line chemotherapy (CT) improved the outcomes of advanced NSCLC. Nonetheless, no direct comparison exists between these combination treatments. METHODS: We performed a meta-an...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Federico, Alessandro, De Giglio, Andrea, Parisi, Claudia, Gelsomino, Francesco, Boni, Luca, Ardizzoni, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474263/
https://www.ncbi.nlm.nih.gov/pubmed/34590054
http://dx.doi.org/10.1016/j.jtocrr.2021.100214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474263/
https://www.ncbi.nlm.nih.gov/pubmed/34590054
http://dx.doi.org/10.1016/j.jtocrr.2021.100214

Ejemplares similares